fbpx
Donate Toggle Menu

Continuing Medical Education (CME) Information

Jointly provided by The France Foundation and the Kidney Cancer Association.

TARGET AUDIENCE

This educational activity is intended for medical oncologists and urologists who treat patients with kidney cancer. Fellows, trainees, nurses, nurse practitioners, physician assistants, and other healthcare professionals involved in the management of kidney cancer are invited to participate.

STATEMENT OF NEED

Education and interaction surrounding the space of renal cell carcinoma are paramount to improving patient care. This program is targeted to physicians, advocates, and researchers to help promote learning and collaboration for advancement in the renal cancer space.

EDUCATIONAL ACTIVITY LEARNING OBJECTIVES

Upon completion of this course, the participants should be able to:

  • Characterize the various therapies currently available for locally advanced and metastatic renal cell carcinoma
  • Identify the novel approaches to non-clear RCC patient management
  • Understand the role of the tumor microenvironment in kidney cancer
  • Discuss how to design biomarker driven clinical trials in kidney cancer

ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by The France Foundation and the Kidney Cancer Association. The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION

The France Foundation designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All other healthcare professionals completing this course will be issued a statement of participation.

An application has been made to the UEMS EACCME for CME accreditation of this event.